当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析

万孚生物

(300482)

  

流通市值:74.40亿  总市值:80.98亿
流通股本:4.30亿   总股本:4.68亿

万孚生物(300482)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.86亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益557782.02万元,未分配利润338001.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产673416.81万元,负债115634.80万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入581,742,751.092,086,830,072.651,690,175,392.81,245,654,367.05
营业总成本491,970,446.342,249,566,528.361,602,538,044.341,069,201,644.31
其他经营收益
营业利润97,917,656.29-110,415,843.1129,743,948207,841,628.6
利润总额97,178,541.97-114,693,306.93126,619,723.75204,776,981.39
净利润86,122,468.23-69,658,473.46126,434,775.78190,209,871.9
每股收益
其他综合收益18,116,871.3342,498,484.27-66,202.61-37,344.56
综合收益总额104,239,339.56-27,159,989.19126,368,573.17190,172,527.34
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,456,884,307.573,301,305,228.243,275,266,911.173,383,062,415.27
非流动资产:
非流动资产合计3,277,283,824.73,300,371,989.713,377,247,419.333,516,966,307.73
资产总计6,734,168,132.276,601,677,217.956,652,514,330.56,900,028,723
流动负债:
流动负债合计1,072,683,956.681,038,875,368.86421,200,154.01591,777,965.85
非流动负债:
非流动负债合计83,664,022.8589,242,035.91670,831,132.56680,847,270.15
负债合计1,156,347,979.531,128,117,404.771,092,031,286.571,272,625,236
所有者权益(或股东权益):
归属于母公司股东权益合计5,517,163,417.515,414,625,996.425,500,455,052.075,551,415,349.41
股东权益合计5,577,820,152.745,473,559,813.185,560,483,043.935,627,403,487
负债和股东权益合计6,734,168,132.276,601,677,217.956,652,514,330.56,900,028,723
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计602,273,018.232,511,134,882.941,790,338,345.831,154,464,589.94
经营活动现金流出小计384,103,290.172,048,097,322.091,737,629,150.111,210,776,041.2
经营活动产生的现金流量净额218,169,728.06463,037,560.8552,709,195.72-56,311,451.26
投资活动产生的现金流量:
投资活动现金流入小计1,607,461,222.844,661,584,129.733,616,239,150.522,572,611,744
投资活动现金流出小计1,916,196,520.185,079,044,1033,908,280,638.892,776,903,133.96
投资活动产生的现金流量净额-308,735,297.34-417,459,973.27-292,041,488.37-204,291,389.96
筹资活动产生的现金流量:
筹资活动现金流入小计653,096.587,046,953.464,736,302.253,134,503.78
筹资活动现金流出小计0417,389,617.13390,795,827.59230,339,919.71
筹资活动产生的现金流量净额653,096.58-410,342,663.67-386,059,525.34-227,205,415.93
汇率变动对现金及现金等价物的影响-1,385,935.36-1,339,102.5-266,391.73635,699.82
现金及现金等价物净增加额-91,298,408.06-366,104,178.59-625,658,209.72-487,172,557.33
期末现金及现金等价物余额370,700,442461,998,850.06202,444,818.93340,930,471.32
补充资料:
现金及现金等价物的净增加额--366,104,178.59--487,172,557.33
最新报告期:2026-05-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投李虹达,王在存,贺菊颖0.850.941.042026-05-28
华创证券郑辰,李婵娟0.861.021.212026-05-25
信达证券唐爱金0.831.001.202026-05-05
中信证券宋硕,陈竹0.850.981.142026-04-28
开源证券余汝意1.051.241.422026-04-27
TOP↑